Publication: Serum C-reactive protein level in postsplenectomized thalassemic patients
Issued Date
2000-01-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-0034154657
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.83, No.SUPPL. 1 (2000)
Suggested Citation
Arree Pornvoranunt Serum C-reactive protein level in postsplenectomized thalassemic patients. Journal of the Medical Association of Thailand. Vol.83, No.SUPPL. 1 (2000). Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/26322
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Serum C-reactive protein level in postsplenectomized thalassemic patients
Author(s)
Other Contributor(s)
Abstract
C-reactive protein is an established marker for the detection of acute and chronic inflammatory processes. The most potent stimulator for the hepatic synthesis of this protein is interleukin 6. Previous studies have shown that inflammatory cells and inflammatory cytokines, such as interleukin 6, interferon gamma, etc were elevated in postsplenectomized thalassemic patients. The aim of this study was to determine serum C-reactive protein concentration in postsplenectomized β thalassemic patients (β thal/HbE postsplenec), and to compare them with those in nonsplenectomized β thalassemic patients (β thal/HbE), postsplenectomized non thalassemic patients (postsplenec), reactive thrombocytosis (RT), chronic myeloproliferative disorders (MPD) and normal adult volunteers. Serum C-reactive protein concentration as determined by an automatic Behring Nephelometer was carried out in 28 β thal/HbE postsplenec, 22 β thal/HbE, 12 postsplenec, 23 RT, 21 MPD, and 26 healthy adult volunteers. The values of CRP in β thal/HbE postsplenec were significantly higher when compared with β thal/HbE, and normal volunteers (4.1±0.7 vs 1.6±0.4 mg/L P = 0.006, and 4.1±0.7 vs 0.45±0.09 mg/L, P < 0.001). CRP levels in β thal/HbE postsplenec were also higher than the postsplenec group (4.1±0.7 vs 0.19±0.7 mg/L P = 0.095). On the contrary, they were significantly lower than those in RT (4.1±0.7 vs 55.4±14.8 mg/L, P = 0.002). However, when compared to those with MPD, the values were not statistically different (4.1±0.7 vs 17.1±12.3 mg/L, P = 0.871). Interestingly, there was a trend towards increasing C-reactive protein levels in β thal/HbE postsplenec patients with higher platelet count, although no correlation was observed. Besides the inflammatory process, platelet and/or factor(s) that control(s) thrombopoiesis seem(s) to play a role in the high serum C-reactive protein levels in the studied population.
